Next Article in Journal
The Association of Food Insecurity and Risk of Mortality: A Systematic Review and Meta-Analysis of Large-Scale Cohorts
Previous Article in Journal
Lipid Metabolism and Relevance to Chronic Disease
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 17
Issue 11
10.3390/nu17111938
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

First–Second-Trimester Dietary Inflammatory Index and Anemia Risk in the Third Trimester: A Prospective Cohort Study

by
Cong Huang
1,
Zhitan Zhang
1,
Junwei He
1,
Zixin Zhong
1,
Yuxin Ma
1,
Xun Huang
1,
Fan Xia
1,
Hongzhuan Tan
1,
Jing Deng
1,2 and
Mengshi Chen
1,2,*
1
Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha 410013, China
2
Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha 410013, China
*
Author to whom correspondence should be addressed.
Nutrients 2025, 17(11), 1938; https://doi.org/10.3390/nu17111938
Submission received: 9 May 2025 / Revised: 27 May 2025 / Accepted: 4 June 2025 / Published: 5 June 2025
(This article belongs to the Section Nutrition in Women)
Browse Figures
Versions Notes

Abstract

Objectives: Dietary conditions are closely related to maternal health. This study aims to investigate the causal relationship between the first–second-trimester Dietary Inflammatory Index (DII) and developing anemia in the third trimester. Methods: This prospective cohort study comprised 545 pregnant women, with dietary data assessed via a semi-quantitative food frequency questionnaire (FFQ). Hemoglobin levels were obtained by hospital laboratory tests and used to diagnose anemia. Multivariable logistic regression models—adjusted for baseline serum iron, age, pre-pregnancy body mass index (BMI), occupation, education, history of adverse pregnancy outcomes, parity, serum iron, passive smoking exposure, and iron supplementation use during pregnancy—were employed to evaluate the relationships between the first-trimester DII, second-trimester DII, first–second-trimester average DII, and third-trimester anemia. Results: After multivariable adjustment, the first–second-trimester average DII in the pro-inflammatory diet group demonstrated a 3.73-fold elevated risk of third-trimester anemia compared to the anti-inflammatory diet group (Odds Ratio [OR] = 3.73, 95% Confidence Interval [CI]: 1.50–9.25). Conclusions: Pro-inflammatory dietary patterns during pregnancy exhibit a significant correlation with developing third-trimester anemia. This study demonstrates that reducing dietary pro-inflammatory components through prenatal nutrition programs may lower third-trimester anemia risk. Notably, this study carries potential risks of bias, including self-reporting bias in dietary data and incompletely controlled confounding factors (such as unmeasured biomarkers).

1. Introduction

Anemia, the most common hematologic disorder, is an important health concern globally and is more prevalent in the pregnant population. Globally, 36.8% of pregnant women are affected by anemia, marked by significant geographical disparities [1], where developing countries exhibit substantially higher rates than developed nations [2,3]. The prevalence of anemia in pregnancy among Chinese pregnant women is reported to be 23.5% [4]. Previous studies [5,6] have identified an elevated risk of anemia in the third trimester of pregnancy compared to earlier pregnancy stages. Anemia in the third trimester has been confirmed to be significantly associated with elevated risks of postpartum hemorrhage, preterm birth, and other adverse obstetric outcomes [7,8,9], posing substantial threats to maternal and neonatal health.
Anemia in pregnancy is primarily attributed to the dysregulation of iron metabolism, encompassing insufficient iron intake, suboptimal dietary patterns, and low compliance with iron supplementation [10,11]. Nutritional deficiencies, particularly an inadequate intake of protein and vitamins during pregnancy, further increase the risk of developing anemia [12,13]. Iron supplementation during pregnancy serves as a critical strategy for preventing gestational anemia [14]. Contemporary clinical recommendations [15] advocate intermittent iron–folic acid supplementation for pregnancies without anemia, while screening-diagnosed anemia cases necessitate intensified therapeutic protocols involving additional iron intake during pregnancy. Marked disparities in iron supplementation rates exist among pregnant women across different areas of China [4,16]. The iron supplementation rate in rural Northwest China (5.4%) is markedly lower than that in developed regions [17]. However, even with standardized iron supplementation, a subset of pregnant women remains susceptible to anemia [18]. This suggests the existence of mechanisms beyond single nutrient deficiencies [19], including inflammation [20].
The role of inflammation in the incidence and persistence of anemia has attracted growing interest [21]. Inflammatory responses impair erythrocyte homeostasis by interfering with erythropoiesis and regulatory pathways, potentially contributing to heterogeneous anemia subtypes [22,23]. Dietary components are closely associated with inflammatory processes in humans. Red meat (beef, lamb, etc.) is rich in highly bioavailable heme iron [24,25], which is critical in combating iron deficiency anemia and is prioritized in maternal nutrition protocols for prophylactic iron supplementation [26]. However, some studies suggest that red meat may also be associated with elevated serum levels of inflammatory mediators [27,28]; this nutritional paradox triggers a reconsideration of dietary intervention strategies. Therefore, a further understanding of the relationship between inflammation and anemia can provide a basis for a more scientific approach to the dietary prevention of anemia during pregnancy.
The Dietary Inflammatory Index (DII), which quantifies the inflammatory potential of dietary intake [29], offers novel insights into exploring diet–anemia relationships during pregnancy. The DII calculates composite scores through the weighted assessment of 45 dietary components based on their pro-/anti-inflammatory effects derived from the established literature, with higher scores indicating pro-inflammatory diets and lower scores reflecting anti-inflammatory patterns [30]. While the DII has been extensively applied in chronic disease research [31], its utilization in maternal health remains limited. Existing studies in pregnant populations predominantly focus on gestational diabetes and preeclampsia [32,33]. However, studies examining the relationship between the DII and anemia remain scarce, and what is particularly lacking is robust evidence of a causal relationship from prospective cohort studies [30].This prospective cohort study assesses the longitudinal relationship between the first–to–second-trimester DII and subsequent third-trimester anemia risk, with temporality supporting possible causal pathways. The fundamental hypothesis of this study is that a cause–effect relationship exists between the DII during the first–to–second-trimester and third-trimester anemia and that higher DII scores (reflecting a pro-inflammatory diet) serve as a risk factor for anemia in the third trimester. The results may inform the development of anti-inflammatory dietary interventions, potentially reducing the risk of anemia in pregnancy and improving pregnancy outcomes.

2. Materials and Methods

2.1. Study Design and Participants

This study recruited women with singleton pregnancies from a maternal–child healthcare facility in China between 2017 and 2019. The inclusion criteria for pregnant women included the following: registered in obstetrics departments of collaborating hospitals with complete standardized antenatal records; aged 18–45 years; and cognitively competent to provide written informed consent for voluntary study participation.
From 870 initially recruited participants, 545 eligible subjects were included after excluding those with missing key data, acute infections during pregnancy, antibiotic use (participants with acute infections were excluded to eliminate confounding effects [34]), or anemia developed before the third trimester (Figure 1). The study protocol was authorized by the Medical Ethics Committee of Hunan Provincial Maternal and Child Health Care Hospital (No. EC201624), with written informed consent collected from all participants.

2.2. Sample Size Calculation

This study is a prospective cohort design. Based on the existing literature, including multiple studies linking the pregnancy-related Dietary Inflammatory Index (DII) to adverse pregnancy events [35,36,37], we hypothesized a relative risk (RR) of 1.5 with a population exposure rate of 23.8% [4]. Using a significance level of α = 0.05 (two-tailed) and β = 0.1, the target sample size was calculated as 308 participants to achieve adequate statistical power, according to the following epidemiological formula (Formula (1)). This study involved 545 participants, fulfilling the research requirements.
N = ( Z α ⋅ 2 ⋅ p ⋅ q + Z β ⋅ p 0 ⋅ q 0 + p 1 ⋅ q 1 ) 2 ( p 0 − p 1 ) 2

2.3. Survey of Participants’ Information

Baseline characteristics were collected through structured questionnaires at the time of pregnancy registration, including age, occupation, education, pre-pregnancy body mass index (BMI), parity (counting only full-term pregnancies), and adverse pregnancy history (including spontaneous abortion, dystocia, postpartum hemorrhage, etc.). Data on passive smoking, alcohol use, and supplement intake (e.g., calcium, iron, folic acid, vitamins) were obtained via questionnaires during follow-ups in the first and second trimesters. Baseline serum iron levels and hemoglobin values from the first to the third trimester were obtained from hospital laboratory tests.

2.4. Dietary Assessment

Dietary intake was evaluated via a semi-quantitative FFQ during the first (11–13 weeks) and second trimesters (24–27 weeks) of pregnancy. The FFQ comprised 13 food categories: cereals, tubers, vegetables, fruits, poultry and livestock meats, seafood, freshwater products, dairy products, soybean products, nuts, edible oils, beverages, and alcoholic beverages. The FFQ included the following response options for intake frequency: ‘Once or more per day’, ‘Once or more per week’, ‘Once or more per month’, and ‘Never’, along with data on the consumption frequency and serving size per occasion. Each dietary questionnaire was self-administered by the participants. In addition, based on the standardized nutritional labeling of commercially available supplements chosen by participants, we calculated supplemental nutrient intakes after unit normalization. These supplemental values were then combined with dietary sources to compute the DII score.

2.5. DII Calculation

The DII is a validated tool with established construct validity and computational methods [30]. Using data from FFQ-administered dietary assessments and participants’ nutritional supplement records, the daily intakes of 26 components were quantified. These comprised energy, protein, carbohydrates, fats, cholesterol, saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids (PUFAs) (n-3 and n-6 subtypes), dietary fiber, vitamins (A, C, D, E, B1, B2, B3 [niacin], B6, B9 [folate], B12 [cobalamin]), beta-carotene, and minerals (iron, zinc, selenium, magnesium). For each participant, dietary parameters were standardized as Z-scores relative to a global reference database, calculated using the following formula: Z-score = (daily intake − mean)/standard deviation (SD) for each component. To correct for right skewness, the Z-score underwent a centered proportion transformation. Each proportion was weighted by its food parameter effect score, and the cumulative DII score represented the summation of all weighted dietary parameters.
The diet is unstable in the first trimester due to pregnancy reactions (e.g., vomiting) and stabilizes in the third trimester. The two-stage average score of the DII is a truer reflection of the dietary habits of pregnant women during pregnancy. In addition, because of the lag in iron metabolism [38], the development of anemia requires some time for the accumulation of nutritional imbalances. If only the mid-pregnancy diet is analyzed, the effect of the early-pregnancy diet on anemia may be overlooked. Therefore, both DII scores from the first and second trimesters and the averaged DII across these two trimesters were included as exposure variables in the analysis.
Participants were categorized into three distinct groups according to the DII score distribution (25th and 75th percentiles): those with DII scores below the 25th percentile were classified as the anti-inflammatory diet group; individuals with DII scores above the 75th percentile were designated as the pro-inflammatory diet group; and participants scoring between the 25th and 75th percentiles comprised the intermediate group.

2.6. Diagnostic Criteria and Variable Definitions

(1)
Hemoglobin (Hb): Hemoglobin levels are obtained by hospital laboratory tests. WHO standards [31] were applied for anemia diagnosis, using trimester-specific Hb thresholds: <110 g/L (first/third trimesters) and <105 g/L (second trimester) [39].
(2)
BMI: According to Chinese national guidelines [40], BMI was categorized into categories defined as non-overweight (BMI < 24 kg/m2) and overweight (BMI ≥ 24.0 kg/m2).
(3)
Passive smoking exposure: Passive smoking exposure during pregnancy was defined as self-reported regular exposure to secondhand smoke in household or occupational settings, dichotomously categorized based on questionnaire responses (yes/no).

2.7. Covariates

This study adjusted for key covariates to strengthen the causal inference between the DII and anemia, including age (<30 years, ≥30 years), pre-pregnancy BMI (<23.9 kg/m2, ≥24.0 kg/m2), occupation (employed, unemployed), education (below high school, high school and above), history of adverse pregnancy (no, yes), parity (0, ≥1), baseline serum iron (SI), passive smoking exposure (yes/no), and iron supplementation use (yes/no).

2.8. Statistical Analysis

Data entry was conducted utilizing EpiData 3.1 software with dual independent data entry and cross-verification to ensure accuracy. Statistical analysis and plotting were performed using SPSS 26.0 and R 4.4.3. Normally distributed continuous variables (e.g., age, BMI) are presented as the mean ± SD, whereas non-normal data are expressed as the median (IQR). Categorical variables (e.g., occupation, parity, history of adverse pregnancy outcomes) are presented as percentages. Continuous variables adhering to a normal distribution were evaluated via parametric tests. Chi-square tests were used to compare the distribution of participant characteristics across DII tertiles and to assess the relationships between participant characteristics and third-trimester anemia. To address Type I error inflation, the Bonferroni correction was implemented for multiple intergroup comparisons
Multivariable logistic regression models were employed to evaluate the correlation between the gestational DII and third-trimester anemia and reported odds ratios (ORs) and 95% confidence intervals (CIs). Restricted cubic spline regression was used to analyze the dose–response trends between DII scores and anemia risk. The criterion for statistical significance was determined by a two-tailed p-value < 0.05.

3. Results

3.1. Baseline and Pregnancy Characteristics of Participants

This study enrolled 545 participants. The mean age was 29.50 ± 4.28 years, and the pre-pregnancy BMI averaged 20.77 ± 2.64 kg/m2. The baseline serum iron levels were 8.76 ± 0.85 μmol/L. Sociodemographic characteristics indicated that 87.3% of participants completed senior high school or higher education, 88.0% were employed, and 82.3% were primiparous. During pregnancy, 18.9% reported passive smoking exposure, and 42.2% received iron supplementation.
The first trimester DII scores extended from −4.38 to 3.81, with the median (25th percentile, 75th percentile) being 0.12 (−1.29, 1.45). The second-trimester DII scores extended from −4.84 to 3.91. The median and interquartile range (IQR) were 0.33 (−1.12–1.63). The First–second-trimester average DII scores extended from −3.25 to 3.50, with the median (25th percentile, 75th percentile) being 0.24 (−0.95, 1.17).
Table 1 reveals no significant differences in baseline or pregnancy characteristics across the DII groups.

3.2. Incidence of Third-Trimester Anemia

Of the 545 participants, 61 developed anemia during the third trimester, yielding an incidence rate of 11.19%, with all cases classified as mild anemia [4]. As shown in Table 2, baseline characteristic analysis revealed a significantly lower cumulative incidence of anemia in the third trimester among participants exposed to secondhand smoke during pregnancy compared to non-exposed individuals (p < 0.05). Stratified by first–second-trimester average DII groups, the cumulative incidence in the pro-inflammatory diet group was 15.16%, significantly exceeding the 5.19% incidence in the anti-inflammatory diet group (Bonferroni-adjusted p = 0.21).

3.3. Relationship Between First–Second-Trimester DII and Anemia in Third Trimester

We applied logistic regression to evaluate the longitudinal association of the first–second-trimester DII with later third-trimester anemia (Table 3). Adjusted for confounders including age, educational attainment, parity, secondhand smoke exposure, and iron supplementation, the first–second-trimester average DII in the pro-inflammatory diet group exhibited a 3.73-fold elevated risk relative to the anti-inflammatory diet group (OR = 3.73, 95% CI: = 1.50–9.25). In addition, the second-trimester DII scores exhibited a statistically significant association with an increased risk of third-trimester anemia after stepwise adjustment for confounders, with consistent effect magnitudes across all models (p < 0.05). Although first-trimester DII scores demonstrated a positive trend toward anemia risk (OR = 1.15, 95% CI: 0.99–1.34), statistical significance was not attained for this association.
Restricted cubic spline regression further revealed a significant dose-dependent increase in anemia risk with rising second-trimester and first–second-trimester average DII scores (Figure 2).

3.4. Stratified Analysis of Iron Supplementation, DII, and Anemia Risk

Given the established association between anemia and iron supplementation, stratified logistic regression analyses were conducted based on iron supplementation status. In the non-supplemented group (n = 315), a 1-unit rise in the second-trimester DII corresponded to a 41.3% increase in anemia risk (adjusted OR = 1.40, 95% CI= 1.12–1.78, p= 0.004), while a 1-unit increase in the first–second-trimester average DII corresponded to a 62.3% higher risk (adjusted OR = 1.62, 95% CI= 1.19–2.22, p = 0.002). Conversely, no significant associations were observed between the DII and anemia in the iron-supplemented group (n = 230) for either the second-trimester DII (adjusted OR = 1.12, p = 0.321) or average DII (adjusted OR = 1.19, p = 0.199) (Table 4).
Furthermore, interaction effects between the DII and iron supplementation status were assessed via Wald tests, with no statistical significance observed across all trimesters (p > 0.05).

4. Discussion

4.1. Main Findings Compared to Previous Studies

This prospective study systematically examined whether first–second-trimester DII is an influential factor in the development of third-trimester anemia using longitudinal data. It revealed that a pro-inflammatory dietary pattern (higher first–second-trimester average DII score) independently increases the risk of third-trimester anemia (OR = 3.73), with a stronger association observed among pregnant women who did not use iron supplements.
While numerous studies have evaluated the importance of dietary interventions in preventing or treating anemia, traditional research on pregnancy-related anemia has primarily focused on iron supplementation and the correction of single-nutrient deficiencies [41,42,43,44]. For example, strategies to increase iron intake through foods rich in iron (e.g., meat, fish, legumes, and leafy greens) [45,46] or isolated supplementation with vitamin A or other micronutrients [47,48] may improve maternal hemoglobin levels and reduce anemia risk. In contrast, this study utilized the DII to emphasize the importance of diet inflammation and holistic dietary regulation.
Although no prior studies have explicitly examined the relationship between the DII during pregnancy and third-trimester anemia, existing evidence suggests correlations between dietary inflammatory potential and hemoglobin levels. A prospective cohort study [49] on maternal anemia reported that higher DII scores were associated with lower third-trimester hemoglobin values (β = −0.057, p = 0.011). Similarly, analyses from the NEHANS database indicated that an elevated DII increases anemia susceptibility in the general population (OR = 1.06) [50]. Unlike previous studies, our research, based on a rigorously designed cohort excluding individuals with acute infections (which may transiently elevate inflammatory markers) and adjusting for baseline serum iron levels and iron supplementation, confirms the DII as an independent contributor to anemia risk during the third trimester.
Mechanistically, there exists a close interplay between diet, inflammation, and anemia. Elevated levels of pro-inflammatory biomarkers (e.g., IL-6, CRP) have been consistently linked to higher DII values in prior research [51,52]. Pro-inflammatory diets, as shown by high DII values, trigger systemic inflammation [53], which may mechanistically contribute to anemia. Research [54] highlights the critical link between anemia and inflammation. Under inflammatory conditions, macrophages release elevated levels of cytokines, stimulating the hepatic synthesis of hepcidin [55,56]. Hepcidin interacts with ferritin on enterocytes, triggering their internalization and proteolytic degradation and ultimately inhibiting iron absorption by intestinal epithelial cells [57,58]. This iron-restricted state exacerbates iron deficiency, increasing susceptibility to anemia in the third trimester. Concurrently, inflammation may shorten the erythrocytes’ lifespan through oxidative stress and eryptosis [19], further aggravating anemia. Moreover, chronic inflammation elevates the risks of gestational complications—including stillbirth, miscarriage, and placental abruption [59,60]—which may indirectly worsen anemia by compromising maternal nutritional status and physiological resilience. These pathways collectively explain, in part, how an elevated gestational DII increases the risk of third-trimester anemia, though more comprehensive investigations are required to fully characterize these mechanisms. Additionally, this study found a higher incidence of third-trimester anemia in passive smokers compared to the non-exposed group. However, the limited sample size of passive smokers in the anemia subgroup (n = 37) may have constrained the statistical power, necessitating cautious interpretation of this finding.

4.2. Research Significance of This Study

This study reveals a causal relationship between the DII in the first and second trimesters and third-trimester anemia, providing critical evidence for clinical practice and public health policies. At the clinical level, anti-inflammatory dietary interventions (e.g., increased intake of whole grains, dark leafy vegetables, and antioxidant-rich foods) [61] should be incorporated into comprehensive anemia management strategies, with individualized dietary guidance to reduce DII scores, particularly necessary for pregnant women who are not using iron supplements. At the public health level, integrating DII assessment tools [62] to dynamically monitor dietary inflammatory potential and promoting anti-inflammatory dietary concepts through community health education are recommended.

4.3. Limitations and Future Research

Although this study demonstrates a pro-inflammatory dietary model (assessed via the DII) elevates the risk of third-trimester anemia, several limitations should be acknowledged. First, in this study, we chose serum iron as an indicator of iron status due to its completeness and accessibility in the cohort database. However, the lack of anemia-related laboratory biomarkers such as serum ferritin (SF) may result in an inability to accurately reflect iron storage levels, which may affect the accuracy of our findings. Second, while pre-pregnancy BMI was included in analyses, gestational weight gain—a potential confounder—was not accounted for. Third, the self-administered nature of dietary questionnaires may introduce recall or reporting bias, which is a limitation of this study.
Future studies with expanded cohorts and comprehensive biomarker profiling are warranted to explore the relationships of the DII with anemia severity, along with conducting multi-ethnic, multi-regional, multi-center studies to validate the generalizability of the findings. The further refinement of dietary assessment methods and development of a rapid DII evaluation tool tailored for pregnancy are also needed.

5. Conclusions

There was a strong positive correlation between the gestational DII and anemia risk in the third trimester, indicating that pro-inflammatory diets during pregnancy are strongly associated with an elevated risk of this condition. Furthermore, this cause–effect relationship was more pronounced in participants who did not receive iron supplementation. Dietary interventions aimed at avoiding pro-inflammatory dietary patterns during pregnancy may reduce anemia risk in the third trimester, thereby improving maternal and newborn health. The conclusions of this study require cautious interpretation. Although the longitudinal design supports a temporal relationship between the DII and anemia risk, potential biases may arise from recall bias in dietary assessments, residual confounding (e.g., missing biomarkers), and sample size limitations. Future studies integrating biomarker-validated diets and multicenter cohorts are needed to confirm causality between dietary inflammation and anemia during pregnancy.

Author Contributions

M.C.: Conceptualization, Methodology, Supervision; C.H.: Data curation, Investigation, Methodology, Writing—original draft; Z.Z. (Zhitan Zhang), J.H., Z.Z. (Zixin Zhong), Y.M., X.H., F.X.: Data curation, Investigation; H.T., J.D. and M.C.: Writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

The Natural Science Foundation of Hunan Province, China (Grant No. 2024JJ9043) supported this study through the project “Establishment and Evaluation of a Risk Prediction Model for Gestational Diabetes Mellitus”.

Institutional Review Board Statement

The study protocol adhered to the principles of the Declaration of Helsinki. The Medical Ethics Committee of Hunan Maternal and Child Health Hospital, China, approved the protocol on 13 January 2017 (Ethics Approval No. EC201624).

Informed Consent Statement

Written informed consent was acquired from all participants included in the research.

Data Availability Statement

The data presented in this study are available on request from the corresponding author due to participant privacy concerns and legal restrictions related to the confidentiality agreements of the study cohort.

Acknowledgments

We sincerely thank all study participants and contributors to baseline data collection for their invaluable contributions (with explicit consent obtained for acknowledgment).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Karami, M.; Chaleshgar, M.; Salari, N.; Akbari, H.; Mohammadi, M. Global Prevalence of Anemia in Pregnant Women: A Comprehensive Systematic Review and Meta-Analysis. Matern. Child Health J. 2022, 26, 1473–1487. [Google Scholar] [CrossRef] [PubMed]
  2. Araujo, C.E.; de Paula, A.J. Global profile of anemia during pregnancy versus country income overview: 19 years estimative (2000–2019). Ann. Hematol. 2023, 102, 2025–2031. [Google Scholar] [CrossRef] [PubMed]
  3. Stevens, G.A.; Paciorek, C.J.; Flores-Urrutia, M.C.; Borghi, E.; Namaste, S.; Wirth, J.P.; Suchdev, P.S.; Ezzati, M.; Rohner, F.; Flaxman, S.R.; et al. National, regional, and global estimates of anaemia by severity in women and children for 2000-19: A pooled analysis of population-representative data. Lancet Glob. Health 2022, 10, e627–e639. [Google Scholar] [CrossRef] [PubMed]
  4. Lin, L.; Wei, Y.; Zhu, W.; Wang, C.; Su, R.; Feng, H.; Yang, H. Prevalence, risk factors and associated adverse pregnancy outcomes of anaemia in Chinese pregnant women: A multicentre retrospective study. BMC Pregnancy Childbirth 2018, 18, 111. [Google Scholar] [CrossRef]
  5. Zerfu, T.A.; Baye, K.; Faber, M. Dietary diversity cutoff values predicting anemia varied between mid and term of pregnancy: A prospective cohort study. J. Health Popul. Nutr. 2019, 38, 44. [Google Scholar] [CrossRef]
  6. Zhao, S.Y.; Jing, W.Z.; Liu, J.; Liu, M. Prevalence of anemia during pregnancy in China, 2012–2016: A Meta-analysis. Zhonghua Yu Fang Yi Xue Za Zhi 2018, 52, 951–957. [Google Scholar] [CrossRef]
  7. Shand, A.W.; Kidson-Gerber, G.L. Anaemia in pregnancy: A major global health problem. Lancet 2023, 401, 1550–1551. [Google Scholar] [CrossRef]
  8. Xiong, X.; Buekens, P.; Fraser, W.D.; Guo, Z. Anemia during pregnancy in a Chinese population. Int. J. Gynecol. Obstet. 2003, 83, 159–164. [Google Scholar] [CrossRef]
  9. Moeller, S.L.; Schmiegelow, C.; Larsen, L.G.; Nielsen, K.; Msemo, O.A.; Lusingu, J.; Minja, D.; Theander, T.G.; Bygbjerg, I.C.; Nyengaard, J.R. Anemia in late pregnancy induces an adaptive response in fetoplacental vascularization. Placenta 2019, 80, 49–58. [Google Scholar] [CrossRef]
  10. Zhang, J.; Li, Q.; Song, Y.; Fang, L.; Huang, L.; Sun, Y. Nutritional factors for anemia in pregnancy: A systematic review with meta-analysis. Front. Public Health 2022, 10, 1041136. [Google Scholar] [CrossRef]
  11. Glonnegger, H.; Glenzer, M.M.; Lancaster, L.; Barnes, R.; von Drygalski, A. Prepartum Anemia and Risk of Postpartum Hemorrhage: A Meta-Analysis and Brief Review. Clin. Appl. Thromb./Hemost. 2023, 29, 10760296231214536. [Google Scholar] [CrossRef] [PubMed]
  12. Tadesse, S.E.; Seid, O.; Mariam, Y.G.; Fekadu, A.; Wasihun, Y.; Endris, K.; Bitew, A. Determinants of anemia among pregnant mothers attending antenatal care in Dessie town health facilities, northern central Ethiopia, unmatched case-control study. PLoS ONE 2017, 12, e173173. [Google Scholar] [CrossRef] [PubMed]
  13. Das, A.; Bai, C.H.; Chang, J.S.; Huang, Y.L.; Wang, F.F.; Chen, Y.C.; Chao, J.C. Associations of Dietary Patterns and Vitamin D Levels with Iron Status in Pregnant Women: A Cross-Sectional Study in Taiwan. Nutrients 2023, 15, 1805. [Google Scholar] [CrossRef] [PubMed]
  14. Pasricha, S.R.; Tye-Din, J.; Muckenthaler, M.U.; Swinkels, D.W. Iron deficiency. Lancet 2021, 397, 233–248. [Google Scholar] [CrossRef]
  15. Chinese Medical Association Hematology Branch Red Cell Disorders (Anemia) Group. Multidisciplinary expert consensus on the diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia (2022 edition). Natl. Med. J. China 2022, 102, 3246–3256. [Google Scholar] [CrossRef]
  16. Li, S.; Zhao, L.; Yu, D.; Ren, H. Attention Should Be Paid to Adolescent Girl Anemia in China: Based on China Nutrition and Health Surveillance (2015–2017). Nutrients 2022, 14, 2449. [Google Scholar] [CrossRef]
  17. Liu, D.; Cheng, Y.; Dang, S.; Wang, D.; Zhao, Y.; Li, C.; Li, S.; Lei, F.; Qu, P.; Mi, B.; et al. Maternal adherence to micronutrient supplementation before and during pregnancy in Northwest China: A large-scale population-based cross-sectional survey. BMJ Open 2019, 9, e028843. [Google Scholar] [CrossRef]
  18. Annan, R.A.; Gyimah, L.A.; Apprey, C.; Edusei, A.K.; Asamoah-Boakye, O.; Aduku, L.; Azanu, W.; Lutterodt, H.E. Factors associated with iron deficiency anaemia among pregnant teenagers in Ashanti Region, Ghana: A hospital-based prospective cohort study. PLoS ONE 2021, 16, e0250246. [Google Scholar] [CrossRef]
  19. Chaparro, C.M.; Suchdev, P.S. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann. N. Y. Acad. Sci. 2019, 1450, 15–31. [Google Scholar] [CrossRef]
  20. Musina, N.N.; Saprina, T.V.; Prokhorenko, T.S.; Kanev, A.; Zima, A.P. Correlations between Iron Metabolism Parameters, Inflammatory Markers and Lipid Profile Indicators in Patients with Type 1 and Type 2 Diabetes Mellitus. J. Pers. Med. 2020, 10, 70. [Google Scholar] [CrossRef]
  21. Weiss, G.; Ganz, T.; Goodnough, L.T. Anemia of inflammation. Blood 2019, 133, 40–50. [Google Scholar] [CrossRef] [PubMed]
  22. Rosenblum, S.L. Inflammation, dysregulated iron metabolism, and cardiovascular disease. Front. Aging 2023, 4, 1124178. [Google Scholar] [CrossRef] [PubMed]
  23. Chen, S.; Xiao, J.; Cai, W.; Lu, X.; Liu, C.; Dong, Y.; Zheng, Y.; Song, G.; Sun, Q.; Wang, H.; et al. Association of the systemic immune-inflammation index with anemia: A population-based study. Front. Immunol. 2024, 15, 1391573. [Google Scholar] [CrossRef] [PubMed]
  24. Czerwonka, M.; Tokarz, A. Iron in red meat-friend or foe. Meat Sci. 2017, 123, 157–165. [Google Scholar] [CrossRef]
  25. McAfee, A.J.; McSorley, E.M.; Cuskelly, G.J.; Moss, B.W.; Wallace, J.M.; Bonham, M.P.; Fearon, A.M. Red meat consumption: An overview of the risks and benefits. Meat Sci. 2010, 84, 1–13. [Google Scholar] [CrossRef]
  26. Jackson, J.; Williams, R.; McEvoy, M.; MacDonald-Wicks, L.; Patterson, A. Is Higher Consumption of Animal Flesh Foods Associated with Better Iron Status among Adults in Developed Countries? A Systematic Review. Nutrients 2016, 8, 89. [Google Scholar] [CrossRef]
  27. Shiraseb, F.; Hosseininasab, D.; Mirzababaei, A.; Bagheri, R.; Wong, A.; Suzuki, K.; Mirzaei, K. Red, white, and processed meat consumption related to inflammatory and metabolic biomarkers among overweight and obese women. Front. Nutr. 2022, 9, 1015566. [Google Scholar] [CrossRef]
  28. Campmans-Kuijpers, M.; Dijkstra, G. Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID). Nutrients 2021, 13, 1067. [Google Scholar] [CrossRef]
  29. Shivappa, N.; Wirth, M.D.; Hurley, T.G.; Hebert, J.R. Association between the dietary inflammatory index (DII) and telomere length and C-reactive protein from the National Health and Nutrition Examination Survey-1999–2002. Mol. Nutr. Food Res. 2017, 61, 1600630. [Google Scholar] [CrossRef]
  30. Shivappa, N.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Hebert, J.R. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014, 17, 1689–1696. [Google Scholar] [CrossRef]
  31. Namazi, N.; Larijani, B.; Azadbakht, L. Dietary Inflammatory Index and its Association with the Risk of Cardiovascular Diseases, Metabolic Syndrome, and Mortality: A Systematic Review and Meta-Analysis. Horm. Metab. Res. 2018, 50, 345–358. [Google Scholar] [CrossRef] [PubMed]
  32. Lecorguille, M.; Teo, S.; Phillips, C.M. Maternal Dietary Quality and Dietary Inflammation Associations with Offspring Growth, Placental Development, and DNA Methylation. Nutrients 2021, 13, 3130. [Google Scholar] [CrossRef] [PubMed]
  33. Soltani, S.; Aminianfar, A.; Hajianfar, H.; Azadbakht, L.; Shahshahan, Z.; Esmaillzadeh, A. Association between dietary inflammatory potential and risk of developing gestational diabetes: A prospective cohort study. Nutr. J. 2021, 20, 48. [Google Scholar] [CrossRef] [PubMed]
  34. Canny, S.P.; Orozco, S.L.; Thulin, N.K.; Hamerman, J.A. Immune Mechanisms in Inflammatory Anemia. Annu. Rev. Immunol. 2023, 41, 405–429. [Google Scholar] [CrossRef]
  35. Wang, W.; Dong, Y.; Wang, K.; Sun, H.; Yu, H.; Ling, B. Dietary Inflammatory Index and female infertility: Findings from NHANES survey. Front. Nutr. 2024, 11, 1391983. [Google Scholar] [CrossRef]
  36. Casas, R.; Castro-Barquero, S.; Crovetto, F.; Larroya, M.; Ruiz-Leon, A.M.; Segales, L.; Nakaki, A.; Youssef, L.; Benitez, L.; Casanovas-Garriga, F.; et al. Maternal Dietary Inflammatory Index during Pregnancy Is Associated with Perinatal Outcomes: Results from the IMPACT BCN Trial. Nutrients 2022, 14, 2284. [Google Scholar] [CrossRef]
  37. Liu, P.; Maharjan, R.; Wang, Y.; Zhang, Y.; Zhang, Y.; Xu, C.; Geng, Y.; Miao, J. Association between dietary inflammatory index and risk of endometriosis: A population-based analysis. Front. Nutr. 2023, 10, 1077915. [Google Scholar] [CrossRef]
  38. Schirm, S.; Scholz, M. A biomathematical model of human erythropoiesis and iron metabolism. Sci. Rep. 2020, 10, 8602. [Google Scholar] [CrossRef]
  39. Guideline on Haemoglobin Cutoffs to Define Anaemia in Individuals and Populations; World Health Organization: Geneva, Switzerland, 2024.
  40. Chen, C.; Lu, F.C. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed. Environ. Sci. 2004, 17, 1–36. [Google Scholar]
  41. Nicholson, W.K.; Silverstein, M.; Wong, J.B.; Chelmow, D.; Coker, T.R.; Davis, E.M.; Jaen, C.R.; Krousel-Wood, M.; Lee, S.; Li, L.; et al. Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement. JAMA 2024, 332, 906–913. [Google Scholar] [CrossRef]
  42. Jugha, V.T.; Anchang-Kimbi, J.K.; Anchang, J.A.; Mbeng, K.A.; Kimbi, H.K. Dietary Diversity and Its Contribution in the Etiology of Maternal Anemia in Conflict Hit Mount Cameroon Area: A Cross-Sectional Study. Front. Nutr. 2020, 7, 625178. [Google Scholar] [CrossRef]
  43. Gibore, N.S.; Ngowi, A.F.; Munyogwa, M.J.; Ali, M.M. Dietary Habits Associated with Anemia in Pregnant Women Attending Antenatal Care Services. Curr. Dev. Nutr. 2021, 5, nzaa178. [Google Scholar] [CrossRef]
  44. Skolmowska, D.; Glabska, D.; Kolota, A.; Guzek, D. Effectiveness of Dietary Interventions in Prevention and Treatment of Iron-Deficiency Anemia in Pregnant Women: A Systematic Review of Randomized Controlled Trials. Nutrients 2022, 14, 3023. [Google Scholar] [CrossRef]
  45. Aspuru, K.; Villa, C.; Bermejo, F.; Herrero, P.; Lopez, S.G. Optimal management of iron deficiency anemia due to poor dietary intake. Int. J. Gen. Med. 2011, 4, 741–750. [Google Scholar] [CrossRef]
  46. Achebe, M.M.; Gafter-Gvili, A. How I treat anemia in pregnancy: Iron, cobalamin, and folate. Blood 2017, 129, 940–949. [Google Scholar] [CrossRef]
  47. Da, S.L.K.; Yamaji, N.; Rahman, M.O.; Suto, M.; Takemoto, Y.; Garcia-Casal, M.N.; Ota, E. Nutrition-specific interventions for preventing and controlling anemia throughout the life cycle: An overview of systematic reviews. Cochrane Database Syst. Rev. 2021, 9, CD013092. [Google Scholar] [CrossRef]
  48. Abe, S.K.; Balogun, O.O.; Ota, E.; Takahashi, K.; Mori, R. Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby. Cochrane Database Syst. Rev. 2016, 2, CD010647. [Google Scholar] [CrossRef]
  49. Hayashi, I.; Sakane, N.; Suganuma, A.; Nagai, N. Association of a pro-inflammatory diet and gestational diabetes mellitus with maternal anemia and hemoglobin levels during pregnancy: A prospective observational case-control study. Nutr. Res. 2023, 115, 38–46. [Google Scholar] [CrossRef]
  50. Ma, H.; Deng, W.; Chen, H.; Ding, X. Association between dietary inflammatory index and anemia in US adults. Front. Nutr. 2023, 10, 1310345. [Google Scholar] [CrossRef]
  51. Goodwin, T.M.; Ramin, S.M. Practice Bulletin Summary No. 153: Nausea and Vomiting of Pregnancy. Obstet. Gynecol. 2015, 126, 687–688. [Google Scholar] [CrossRef]
  52. Pieczynska, J.; Placzkowska, S.; Pawlik-Sobecka, L.; Kokot, I.; Sozanski, R.; Grajeta, H. Association of Dietary Inflammatory Index with Serum IL-6, IL-10, and CRP Concentration during Pregnancy. Nutrients 2020, 12, 2789. [Google Scholar] [CrossRef]
  53. Lee, Y.J.; Seo, J.A.; Yoon, T.; Seo, I.; Lee, J.H.; Im, D.; Lee, J.H.; Bahn, K.N.; Ham, H.S.; Jeong, S.A.; et al. Effects of low-fat milk consumption on metabolic and atherogenic biomarkers in Korean adults with the metabolic syndrome: A randomised controlled trial. J. Hum. Nutr. Diet. 2016, 29, 477–486. [Google Scholar] [CrossRef]
  54. Weiss, G.; Goodnough, L.T. Anemia of chronic disease. N. Engl. J. Med. 2005, 352, 1011–1023. [Google Scholar] [CrossRef]
  55. Theurl, I.; Aigner, E.; Theurl, M.; Nairz, M.; Seifert, M.; Schroll, A.; Sonnweber, T.; Eberwein, L.; Witcher, D.R.; Murphy, A.T.; et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications. Blood 2009, 113, 5277–5286. [Google Scholar] [CrossRef]
  56. Lanser, L.; Fuchs, D.; Kurz, K.; Weiss, G. Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis-Mechanistic Insights into Anemia of Inflammation and Its Treatment. Nutrients 2021, 13, 3732. [Google Scholar] [CrossRef]
  57. Nemeth, E.; Ganz, T. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. Int. J. Mol. Sci. 2021, 22, 6493. [Google Scholar] [CrossRef]
  58. Galy, B.; Conrad, M.; Muckenthaler, M. Mechanisms controlling cellular and systemic iron homeostasis. Nat. Rev. Mol. Cell Biol. 2024, 25, 133–155. [Google Scholar] [CrossRef]
  59. Giles, M.L.; Way, S.S.; Marchant, A.; Aghaepour, N.; James, T.; Schaltz-Buchholzer, F.; Zazara, D.; Arck, P.; Kollmann, T.R. Maternal Vaccination to Prevent Adverse Pregnancy Outcomes: An Underutilized Molecular Immunological Intervention? J. Mol. Biol. 2023, 435, 168097. [Google Scholar] [CrossRef]
  60. Blackwell, C. The Role of Infection and Inflammation in Stillbirths: Parallels with SIDS? Front. Immunol. 2015, 6, 248. [Google Scholar] [CrossRef]
  61. Skoczek-Rubinska, A.; Muzsik-Kazimierska, A.; Chmurzynska, A.; Jamka, M.; Walkowiak, J.; Bajerska, J. Inflammatory Potential of Diet Is Associated with Biomarkers Levels of Inflammation and Cognitive Function among Postmenopausal Women. Nutrients 2021, 13, 2323. [Google Scholar] [CrossRef]
  62. Hebert, J.R.; Shivappa, N.; Wirth, M.D.; Hussey, J.R.; Hurley, T.G. Perspective: The Dietary Inflammatory Index (DII)-Lessons Learned, Improvements Made, and Future Directions. Adv. Nutr. 2019, 10, 185–195. [Google Scholar] [CrossRef] [PubMed]
Nutrients 17 01938 g001
Figure 1. Inclusion and exclusion flow chart.
Figure 1. Inclusion and exclusion flow chart.
Nutrients 17 01938 g001
Nutrients 17 01938 g002
Figure 2. Sample regression model for second-trimester DII (A), first–second-trimester average DII (B), and third-trimester anemia. Restricted cubic spline regression was adjusted for age, pre-pregnancy BMI, education, occupation, parity, serum iron, and a history of adverse pregnancy outcomes, passive smoking exposure and iron supplementation.
Figure 2. Sample regression model for second-trimester DII (A), first–second-trimester average DII (B), and third-trimester anemia. Restricted cubic spline regression was adjusted for age, pre-pregnancy BMI, education, occupation, parity, serum iron, and a history of adverse pregnancy outcomes, passive smoking exposure and iron supplementation.
Nutrients 17 01938 g002
Table 1. Comparison of baseline characterization by three groups of first–second-trimester average DII.
Table 1. Comparison of baseline characterization by three groups of first–second-trimester average DII.
VariableTotal
(n = 545)		Anti-Inflammatory Diet Group
(n = 136)		Intermediate Group (n = 273)Pro-Inflammatory Diet Group
(n = 136)		p 1
Baseline serum iron8.76 ± 0.858.69 ± 0.868.76 ± 0.848.81 ± 0.870.502
Maternal age, n (%) 0.869
<30 years310 (56.88)77 (56.62)158 (57.88)75 (55.15)
≥30 years235 (43.12)59 (43.38)115 (42.12)61 (44.85)
Occupation, n (%) 0.570
Employed479 (87.89)123 (90.44)238 (87.18)118 (86.76)
Unemployed66 (12.11)13 (9.56)35 (12.82)18 (13.24)
Pre-pregnancy
BMI, n (%)		 0.803
<24 kg/m2478 (87.71)121 (88.97)237 (86.81)120 (88.24)
≥24 kg/m267 (12.29)15 (11.03)36 (13.19)16 (11.76)
Education, n (%) 0.692
Below high school69 (12.66)20 (14.71)32 (11.72)17 (12.50)
High school and above476 (87.34)116 (85.29)241 (88.28)119 (87.50)
Parity, n (%) 0.322
0330 (60.55)89 (65.44)164 (60.07)77 (56.62)
≥1215 (39.45)47 (34.56)109 (39.93)59 (43.38)
History of adverse pregnancy, n (%) 0.583
No324 (59.45)86 (63.24)159 (58.24)79 (58.09)
Yes221 (40.55)50 (36.76)114 (41.76)57 (41.91)
Passive smoking exposure, n (%) 0.088
No442 (81.10)119 (87.50)216 (79.12)107 (78.68)
Yes103 (18.90)17 (12.50)57 (20.88)29 (21.32)
Iron supplementation use, n (%) 0.562
Yes231 (42.39)63 (46.32)112 (41.03)56 (41.18)
No314 (57.61)73 (53.68)161 (58.97)80 (58.82)
Note: 1 Categorical and continuous variables were evaluated via the χ2 test and the Kruskal–Wallis test, respectively, to derive p values.
Table 2. Univariate analysis of third-trimester anemia risk factors.
Table 2. Univariate analysis of third-trimester anemia risk factors.
VariableNumber of ParticipantsNumber of CasesCumulative Incidence (%)Statisticp
Maternal age χ2 = 0.130.721
<30 years3103611.61
≥30 years2352510.64
Pre-pregnancy
BMI		 χ2 = 3.470.063
<244785812.13
≥246734.48
Occupation χ2 = 0.330.563
Employed66611.48
Unemployed479559.09
Education χ2 = 3.470.063
Below high school67315.94
High school and above4785810.50
History of adverse pregnancy χ2 = 0.390.531
No3243410.49
Yes2212712.22
Parity χ2 = 1.880.211
0330329.70
≥12152913.49
Passive smoking exposure χ2 = 5.130.023
No4425612.67
Yes10354.85
Iron supplementation use χ2 = 0.750.411
Yes3143212.55
No2312910.19
First–second-trimester average DII χ2 = 7.670.022
Anti-inflammatory diet group13575.19 a
Intermediate group2753312.00 a,b
Pro-inflammatory diet group1352115.56 b
Note: Superscript letters (a, b) indicate the results of pairwise comparisons among groups using the Bonferroni correction. Groups sharing the same superscript letter (a, b) exhibit no statistically significant differences; those with different letters indicate significance.
Table 3. Relationship between first–second-trimester DII and anemia in third trimester (OR and 95% CI).
Table 3. Relationship between first–second-trimester DII and anemia in third trimester (OR and 95% CI).
Duration of PregnancyModel I 1
OR (95% CI)		pModel II 2
OR (95% CI)		pModel III 3
OR (95% CI)		p
First-trimester DII1.15 (0.99–1.33)0.0651.14 (0.98–1.32)0.0921.15 (0.99–1.34)0.067
Second-trimester DII1.23 (1.05–1.44)0.0091.23 (1.05–1.45)0.0091.26 (1.08–1.48)0.004
First–second-trimester average DII (groups)
Anti-inflammatory diet group (Ref)1 1 1
Intermediate group2.53 (1.09–5.89)0.0312.53 (1.09–5.89)0.0302.82 (1.20–6.63)0.017
Pro-inflammatory diet group3.37 (1.38–8.21)0.0083.37 (1.38–8.21)0.0093.73 (1.50–9.25)0.005
Note: 1 Model I represents the basic model; 2 Model II accounted for potential confounders, including age, pre-pregnancy BMI, education, occupation, parity, serum iron, and a history of adverse pregnancy outcomes; 3 Model III further adjusted for passive smoking exposure and iron supplementation based on Model II.
Table 4. Stratified analysis of iron supplementation, DII, and anemia risk.
Table 4. Stratified analysis of iron supplementation, DII, and anemia risk.
DII ScoreNon-Users of Iron Supplement Users of Iron Supplements
aOR 1 (95% CI)paOR 1 (95% CI)p
Second-trimester DII1.40 (1.12–1.78)0.0041.12 (0.90–1.41)0.321
First–second-trimester average DII1.62 (1.19–2.22)0.0021.19 (0.91–1.54)0.199
Note: 1 Logistic regression models accounted for potential confounders: age, pre-pregnancy BMI, education, occupation, adverse pregnancy outcomes, parity, serum iron, passive smoking exposure, and iron supplementation.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Huang, C.; Zhang, Z.; He, J.; Zhong, Z.; Ma, Y.; Huang, X.; Xia, F.; Tan, H.; Deng, J.; Chen, M. First–Second-Trimester Dietary Inflammatory Index and Anemia Risk in the Third Trimester: A Prospective Cohort Study. Nutrients 2025, 17, 1938. https://doi.org/10.3390/nu17111938

AMA Style

Huang C, Zhang Z, He J, Zhong Z, Ma Y, Huang X, Xia F, Tan H, Deng J, Chen M. First–Second-Trimester Dietary Inflammatory Index and Anemia Risk in the Third Trimester: A Prospective Cohort Study. Nutrients. 2025; 17(11):1938. https://doi.org/10.3390/nu17111938

Chicago/Turabian Style

Huang, Cong, Zhitan Zhang, Junwei He, Zixin Zhong, Yuxin Ma, Xun Huang, Fan Xia, Hongzhuan Tan, Jing Deng, and Mengshi Chen. 2025. "First–Second-Trimester Dietary Inflammatory Index and Anemia Risk in the Third Trimester: A Prospective Cohort Study" Nutrients 17, no. 11: 1938. https://doi.org/10.3390/nu17111938

APA Style

Huang, C., Zhang, Z., He, J., Zhong, Z., Ma, Y., Huang, X., Xia, F., Tan, H., Deng, J., & Chen, M. (2025). First–Second-Trimester Dietary Inflammatory Index and Anemia Risk in the Third Trimester: A Prospective Cohort Study. Nutrients, 17(11), 1938. https://doi.org/10.3390/nu17111938

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop